BIOA Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action LawsuitRADNOR, PA - March 4, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, IIPR, FTAI, and Revance and Encourages Investors to Contact the FirmNEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioAge Labs, Inc. (
NASDAQBIOA), Innovative Industrial Properties, Inc.
NYSE:IIPRNYSEIIPR)
(NASDAQ:FTAINASDAQFTAI
, and Revance Therapeutics, Inc. (NASDAQ:RVNCNASDAQ
). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options
BIOA DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Deadline and Encourages Investors With Losses to Contact the FirmRADNOR, PA - March 2, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BIOA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. (BIOA)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BIOA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. (BIOA)RADNOR, PA - February 28, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BioAge Labs, Inc. Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BioAge Labs, Inc. Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPRADNOR, PA - February 26, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BIOA INVESTOR ALERT: Kirby McInerney LLP Reminds BioAge Labs, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
The law firm of Kirby McInerney LLP notifies investors of the approaching March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (
NASDAQBIOA) securities from September 22, 2024, through January 7, 2025 (“the Class Period”).
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, Nextracker, FTAI, and Revance and Encourages Investors to Contact the FirmNEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioAge Labs, Inc. (
NASDAQBIOA), Nextracker Inc.
NASDAQ:NXTNASDAQNXT)
(NASDAQ:FTAINASDAQFTAI
, and Revance Therapeutics, Inc. (NASDAQ:RVNCNASDAQ
). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
BIOA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc.RADNOR, PA - February 24, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Lead Plaintiff Deadline on March 10, 2025 for BIOA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors With Losses to Contact the FirmRADNOR, PA - February 23, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care ConferenceRICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in one-on-one meetings at TD Cowen's 45th Annual Health Care Conference.
BIOA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. (BIOA)RADNOR, PA - February 20, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options
